SARS-CoV-2 感染过程中唾液 RT-PCR 敏感性的变化。
Change in Saliva RT-PCR Sensitivity Over the Course of SARS-CoV-2 Infection.
机构信息
Division of Infectious Diseases, Children's Hospital Los Angeles, Los Angeles, California.
Department of Pediatrics, University of Southern California, Los Angeles.
出版信息
JAMA. 2021 Sep 21;326(11):1065-1067. doi: 10.1001/jama.2021.13967.
Abstract
This study investigates the timeframe that optimizes saliva sensitivity for SARS-CoV-2 detection using reverse transcriptase–polymerase chain reaction (RT-PCR) testing.
摘要
本研究旨在探讨使用逆转录-聚合酶链反应（RT-PCR）检测 SARS-CoV-2 时优化唾液灵敏度的时间范围。
相似文献
1
Change in Saliva RT-PCR Sensitivity Over the Course of SARS-CoV-2 Infection.
JAMA. 2021 Sep 21;326(11):1065-1067. doi: 10.1001/jama.2021.13967.
2
Assessment of Multiplex Digital Droplet RT-PCR as a Diagnostic Tool for SARS-CoV-2 Detection in Nasopharyngeal Swabs and Saliva Samples.
Clin Chem. 2021 Apr 29;67(5):736-741. doi: 10.1093/clinchem/hvaa323.
3
A Multiplex One-Step RT-qPCR Protocol to Detect SARS-CoV-2 in NP/OP Swabs and Saliva.
Curr Protoc. 2021 May;1(5):e145. doi: 10.1002/cpz1.145.
4
Pooling of nasopharyngeal swab specimens for SARS-CoV-2 detection by RT-PCR.
J Med Virol. 2020 Nov;92(11):2306-2307. doi: 10.1002/jmv.25971. Epub 2020 Jun 2.
5
Concentrating Pooled COVID-19 Patient Lysates to Improve Reverse Transcription Quantitative PCR Sensitivity and Efficiency.
Clin Chem. 2021 Apr 29;67(5):797-798. doi: 10.1093/clinchem/hvab035.
6
Comparison of SARS-CoV-2 PCR-Based Detection Using Saliva or Nasopharyngeal Swab Specimens in Asymptomatic Populations.
Microbiol Spectr. 2021 Sep 3;9(1):e0006221. doi: 10.1128/Spectrum.00062-21. Epub 2021 Aug 25.
7
Pooling for SARS-CoV-2-testing: comparison of three commercially available RT-qPCR kits in an experimental approach.
Clin Chem Lab Med. 2021 Jan 20;59(6):e243-e245. doi: 10.1515/cclm-2020-1375. Print 2021 May 26.
8
SARS-CoV-2 in saliva, oropharyngeal and nasopharyngeal specimens.
Dan Med J. 2021 Apr 7;68(5):A01210087.
9
The evaluation of the utility of the GENECUBE HQ SARS-CoV-2 for anterior nasal samples and saliva samples with a new rapid examination protocol.
PLoS One. 2021 Dec 31;16(12):e0262159. doi: 10.1371/journal.pone.0262159. eCollection 2021.
10
Extraction-Free Methods for the Detection of SARS-CoV-2 by Reverse Transcription-PCR: a Comparison with the Cepheid Xpert Xpress SARS-CoV-2 Assay across Two Medical Centers.
J Clin Microbiol. 2021 Jan 21;59(2). doi: 10.1128/JCM.02643-20.
引用本文的文献
1
Rapid Recovery From SARS-CoV-2 Infection Among Immunocompromised Children Despite Limited Neutralizing Antibody Response: A Virologic and Sero-Immunologic Analysis of a Single-Center Cohort.
J Korean Med Sci. 2025 Mar 31;40(12):e52. doi: 10.3346/jkms.2025.40.e52.
2
Detection of Severe Acute Respiratory Syndrome Coronavirus 2 in Pregnant Women Treated with Nirmatrelvir/Ritonavir (Paxlovid) Using Salivary Polymerase Chain Reaction: A Prospective Cohort Study.
Microorganisms. 2024 Dec 12;12(12):2566. doi: 10.3390/microorganisms12122566.
3
The effect of sample site and collection procedure on identification of SARS-CoV-2 infection.
Cochrane Database Syst Rev. 2024 Dec 16;12(12):CD014780. doi: 10.1002/14651858.CD014780.
4
SARS-CoV-2 Variants May Affect Saliva RT-PCR Assay Sensitivity.
J Appl Lab Med. 2024 Nov 4;9(6):927-937. doi: 10.1093/jalm/jfae095.
5
Clinical and laboratory characteristics of patients hospitalized with severe COVID-19 in New Orleans, August 2020 to September 2021.
Sci Rep. 2024 Mar 19;14(1):6539. doi: 10.1038/s41598-024-57306-5.
6
Pooling of six respiratory samples for the detection of SARS-CoV-2: A validation and cost study in a cohort in Lima, Peru.
Heliyon. 2023 Aug 3;9(8):e18904. doi: 10.1016/j.heliyon.2023.e18904. eCollection 2023 Aug.
7
Persistence of SARS-CoV-2 in saliva: Implications for late-stage diagnosis and infectious duration.
PLoS One. 2023 Mar 16;18(3):e0282708. doi: 10.1371/journal.pone.0282708. eCollection 2023.
8
Single-walled carbon nanotubes-based RNA protection and extraction improves RT-qPCR sensitivity for SARS-CoV-2 detection.
Anal Chim Acta. 2023 Jan 15;1238:340639. doi: 10.1016/j.aca.2022.340639. Epub 2022 Nov 19.
9
Comparison of secondary attack rate and viable virus shedding between patients with SARS-CoV-2 Delta and Omicron variants: A prospective cohort study.
J Med Virol. 2023 Jan;95(1):e28369. doi: 10.1002/jmv.28369.
10
Direct Nasal Swab for Rapid Test and Saliva as an Alternative Biological Sample for RT-PCR in COVID-19 Diagnosis.
Microbiol Spectr. 2022 Dec 21;10(6):e0199822. doi: 10.1128/spectrum.01998-22. Epub 2022 Dec 1.
本文引用的文献
1
Prospective Comparison of Saliva and Nasopharyngeal Swab Sampling for Mass Screening for COVID-19.
Front Med (Lausanne). 2021 Feb 23;8:621160. doi: 10.3389/fmed.2021.621160. eCollection 2021.
2
Persistent SARS-CoV-2 RNA Shedding Without Evidence of Infectiousness: A Cohort Study of Individuals With COVID-19.
J Infect Dis. 2021 Oct 28;224(8):1362-1371. doi: 10.1093/infdis/jiab107.
3
Correlation Between 3790 Quantitative Polymerase Chain Reaction-Positives Samples and Positive Cell Cultures, Including 1941 Severe Acute Respiratory Syndrome Coronavirus 2 Isolates.
Clin Infect Dis. 2021 Jun 1;72(11):e921. doi: 10.1093/cid/ciaa1491.
4
RT-qPCR assays based on saliva rather than on nasopharyngeal swabs are possible but should be interpreted with caution: results from a systematic review and meta-analysis.
Acta Biomed. 2020 Sep 7;91(3):e2020025. doi: 10.23750/abm.v91i3.10020.
5
Saliva Sampling and Its Direct Lysis, an Excellent Option To Increase the Number of SARS-CoV-2 Diagnostic Tests in Settings with Supply Shortages.
J Clin Microbiol. 2020 Sep 22;58(10). doi: 10.1128/JCM.01659-20.
Zotero 插件